Literature DB >> 1750338

The natural history of screening detected IgA glomerulonephritis in children.

S Hisano1, M Kawano, Y Kaku, I Yamane, K Hatae, K Uragoh, A Matsuzaki, K Ueda.   

Abstract

The clinical course of 43 children with IgA glomerulonephritis detected by mass urine screening was followed for a mean period of 8.1 years. Histological findings were graded according to the severity of glomerular and tubulointerstitial lesions. There was no correlation in the severity of histological grade and clinical outcome between subjects with microscopic hematuria and those with microscopic hematuria and proteinuria nor between those with and without one or more episodes of macroscopic hematuria during the follow-up period. None of the 35 children with proteinuria less than or equal to 1 g/m2/day had severe histological findings or developed renal impairment. In contrast, the 8 children with proteinuria greater than 1 g/m2/day had moderate and severe histological findings. Four of these 8 children developed hypertension or renal insufficiency during the follow-up period. Our study indicates that the outcome of screening detected IgA glomerulonephritis in children correlates with the level of proteinuria and the severity of renal pathology.

Entities:  

Mesh:

Year:  1991        PMID: 1750338     DOI: 10.1111/j.1651-2227.1991.tb11781.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  3 in total

1.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

2.  Treatment of IgA nephropathy in children.

Authors:  U S Alon
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

3.  Comparison of asymptomatic and symptomatic childhood glomerulonephritis progressing to renal failure: a report of Kyushu Pediatric Nephrology Study Group.

Authors:  S Hisano; N Tsuru; Y Itoh; S Hattori; F Yamashita
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.